Donate Now
Research Grants - 2011


Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2011


To view an abstract, select an author from the vertical list on the left.

2011 Grants - D'Adamio

Genetic and Biochemical Analysis of Synaptic Dysfunction in Dementia

Luciano D'Adamio, M.D.
Albert Einstein College of Medicine of Yeshiva University
Bronx, NY

2011 Zenith Fellows Award

Certain forms of dementia or Alzheimer's disease are caused by mutations in specific genes, causing the proteins produced by these genes to malfunction. Two forms of dementia caused by such genetic mutations are Familial Danish Dementia (FDD) and Familial Alzheimer's Disease (FAD). To study these diseases and search for treatments, researchers often create strains of mice or other animal models harboring the same genetic mutation.

Luciano D'Adamio, M.D. and colleagues have created strains of mice with genetic mutations corresponding to the mutations found in humans with FDD and FAD. Using these models, the researchers found that mice with the FDD gene develop impairments in synaptic transmission, the process by which nerve cells send rapid signals and which is crucial for learning and memory. Notably, impairments in synaptic transmission occurred before development of amyloid plaques or other pathologic features of disease. Dr. D'Adamio and colleagues also found that synaptic impairments in FDD mice were prevented by expression of a normal version of the mutated protein, known as BRI2. This effect could be mimicked by a small portion of the BRI2 protein.

Dr. D'Adamio and colleagues have proposed to perform a detailed study of how mutated BRI2 causes synaptic dysfunction, and which parts of the brain are affected. The researchers will also use molecular techniques to determine how BRI2 interacts with the biochemical mechanisms involved in production of beta-amyloid. These studies may help to redefine the molecular pathways involved in brain dysfunction caused by genetic mutations associated with dementia.